Miragen Therapeutics Inc (MGEN):企業の財務・戦略的SWOT分析

◆英語タイトル:Miragen Therapeutics Inc (MGEN) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME279932FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥50,625見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Miragen Therapeutics Inc (MGEN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Miragen Therapeutics Inc (miRagen), formerly Signal Genetics Inc is a clinical stage biopharmaceutical company. The company discovers and develops novel RNA-based therapeutics, with a core focus on microRNAs and their roles in diseases. It focuses on hematological malignancies, neuro-degeneration, fibrosis and cardiovascular disease areas. Miragen lead pipeline products candidates include Cobomarsen (MRG-106), an inhibitor of microRNA-155 for treating blood cancers; Remlarsen (MRG-201), a replacement for miR-29 for treating or preventing pathologic fibrosis and MRG-110, an inhibitor of microRNA-92 for treating ischemic conditions. Miragen is headquartered in Boulder, Colorado, the US.

Miragen Therapeutics Inc Key Recent Developments

Dec 17,2020: miRagen enters into license agreement with Xencor for use of Xtend Antibody Technology for investigational antibodies to treat thyroid eye disease
Nov 10,2020: miRagen reports third quarter 2020 financial results and provides corporate updates
Sep 14,2020: miRagen announces leadership transition and review of strategic alternatives
Aug 05,2020: miRagen reports second quarter 2020 financial results and provides business updates
Jun 18,2020: miRagen strengthens leadership team with appointment of Lee Rauch as chief operating officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Miragen Therapeutics Inc – Key Facts
Miragen Therapeutics Inc – Key Employees
Miragen Therapeutics Inc – Key Employee Biographies
Miragen Therapeutics Inc – Major Products and Services
Miragen Therapeutics Inc – History
Miragen Therapeutics Inc – Company Statement
Miragen Therapeutics Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Miragen Therapeutics Inc – Business Description
R&D Overview
Miragen Therapeutics Inc – Corporate Strategy
Miragen Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Miragen Therapeutics Inc – Strengths
Miragen Therapeutics Inc – Weaknesses
Miragen Therapeutics Inc – Opportunities
Miragen Therapeutics Inc – Threats
Miragen Therapeutics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Miragen Therapeutics Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Miragen Therapeutics Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Miragen Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Dec 17, 2020: miRagen enters into license agreement with Xencor for use of Xtend Antibody Technology for investigational antibodies to treat thyroid eye disease
Nov 10, 2020: miRagen reports third quarter 2020 financial results and provides corporate updates
Sep 14, 2020: miRagen announces leadership transition and review of strategic alternatives
Aug 05, 2020: miRagen reports second quarter 2020 financial results and provides business updates
Jun 18, 2020: Peter Svennilson elected to RAPT Therapeutics board of directors
Jun 18, 2020: miRagen strengthens leadership team with appointment of Lee Rauch as chief operating officer
May 07, 2020: miRagen reports first quarter 2020 financial results and provides corporate update
Apr 23, 2020: Miragen Therapeutics receives loan under Paycheck Protection Program
Apr 08, 2020: CQuentia now offers testing for 2019 novel coronavirus (COVID-19)
Mar 11, 2020: miRagen reports fourth quarter and full year 2019 financial results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Miragen Therapeutics Inc, Key Facts
Miragen Therapeutics Inc, Key Employees
Miragen Therapeutics Inc, Key Employee Biographies
Miragen Therapeutics Inc, Major Products and Services
Miragen Therapeutics Inc, History
Miragen Therapeutics Inc, Subsidiaries
Miragen Therapeutics Inc, Key Competitors
Miragen Therapeutics Inc, Ratios based on current share price
Miragen Therapeutics Inc, Annual Ratios
Miragen Therapeutics Inc, Annual Ratios (Cont...1)
Miragen Therapeutics Inc, Interim Ratios
Miragen Therapeutics Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Miragen Therapeutics Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Miragen Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Miragen Therapeutics Inc (MGEN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Seattle Genetics Inc (SGEN):企業の財務・戦略的SWOT分析
    Seattle Genetics Inc (SGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • HOK Group, Inc.:企業の戦略・SWOT・財務情報
    HOK Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary HOK Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Black Hills Corporation:発電所・企業SWOT分析
    Black Hills Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emplo …
  • mixi, Inc.:企業の戦略・SWOT・財務分析
    mixi, Inc. - Strategy, SWOT and Corporate Finance Report Summary mixi, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • AltaGas Ltd (ALA):企業の財務・戦略的SWOT分析
    AltaGas Ltd (ALA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • MDNA Life Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary MDNA Life Sciences Inc (MDNA) is a molecular diagnostics company that develops molecular tests based on the mitochondrial genome. The company’s prostate core mitomic test is based on the science of mitochondrial DNA, a tissue-based prostate cancer diagnostics for prostate and other cancers. …
  • CardioDx Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CardioDx Inc (CardioDx) is a cardiovascular genomic diagnostics company. It undertakes the development of clinically validated tests in the areas of coronary artery disease, cardiac arrhythmias and heart failure. The company’s flagship product, Corus CAD gene expression test is used for asse …
  • Bryce Corporation:企業の戦略・SWOT・財務分析
    Bryce Corporation - Strategy, SWOT and Corporate Finance Report Summary Bryce Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • BCE Inc.:企業の戦略・SWOT・財務情報
    BCE Inc. - Strategy, SWOT and Corporate Finance Report Summary BCE Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • ITC Holdings Corp.:企業の発電所・SWOT分析2018
    ITC Holdings Corp. - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Atlas Copco AB (ATCO A)-石油・ガス分野:企業M&A・提携分析
    Summary Atlas Copco AB (Atlas Copco) is an industrial productivity solutions provider. It develops and manufactures vacuum solutions, air treatment systems, compressors, assembly systems, construction and mining equipment, and power tools. Its product portfolio includes air and gas compressors, mach …
  • Genus Power Infrastructures Ltd (GENUSPOWER):企業の財務・戦略的SWOT分析
    Summary Genus Power Infrastructures Ltd (Genus Power), a subsidiary of Kailash Group, is an electronic equipment manufacturer that develops and distributes electric energy equipment. The company’s products include metering solution products, engineering construction and contracts, solar energy solut …
  • NaviNet Inc:企業の戦略的SWOT分析
    NaviNet Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Skipton Building Society (SBSB):企業の財務・戦略的SWOT分析
    Skipton Building Society (SBSB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Qingdao Haier Co., Ltd. (600690):企業の財務・戦略的SWOT分析
    Qingdao Haier Co., Ltd. (600690) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Affinivax Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Affinivax Inc (Affinivax) is a biotechnology company that develops vaccines for infectious diseases. The company uses Multiple Antigen Presenting System technology to enable affinity binding of protective polysaccharides and proteins in a single vaccine. It develops vaccine programs for stre …
  • Synthos SA:企業の戦略的SWOT分析
    Synthos SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Elders Limited:企業のM&A・事業提携・投資動向
    Elders Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Elders Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Inovio Pharmaceuticals Inc (INO):企業の財務・戦略的SWOT分析
    Inovio Pharmaceuticals Inc (INO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Autoliv, Inc.:企業の戦略・SWOT・財務情報
    Autoliv, Inc. - Strategy, SWOT and Corporate Finance Report Summary Autoliv, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆